ZA956098B - Method of treating opportunistic infections by administration of substituted azaspirane compounds - Google Patents

Method of treating opportunistic infections by administration of substituted azaspirane compounds

Info

Publication number
ZA956098B
ZA956098B ZA956098A ZA956098A ZA956098B ZA 956098 B ZA956098 B ZA 956098B ZA 956098 A ZA956098 A ZA 956098A ZA 956098 A ZA956098 A ZA 956098A ZA 956098 B ZA956098 B ZA 956098B
Authority
ZA
South Africa
Prior art keywords
administration
opportunistic infections
treating opportunistic
compounds
substituted azaspirane
Prior art date
Application number
ZA956098A
Other languages
English (en)
Inventor
Alison Mary Badger
Peter John Bugelski
Danuta J Herzyk
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA956098B publication Critical patent/ZA956098B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA956098A 1994-07-23 1995-07-21 Method of treating opportunistic infections by administration of substituted azaspirane compounds ZA956098B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9414902A GB9414902D0 (en) 1994-07-23 1994-07-23 Methods

Publications (1)

Publication Number Publication Date
ZA956098B true ZA956098B (en) 1996-05-23

Family

ID=10758802

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA956098A ZA956098B (en) 1994-07-23 1995-07-21 Method of treating opportunistic infections by administration of substituted azaspirane compounds

Country Status (15)

Country Link
EP (1) EP0804201A4 (hu)
JP (1) JPH10503202A (hu)
KR (1) KR970704446A (hu)
CN (1) CN1157564A (hu)
AU (1) AU684384B2 (hu)
BR (1) BR9508332A (hu)
CA (1) CA2195778A1 (hu)
CZ (1) CZ286482B6 (hu)
GB (1) GB9414902D0 (hu)
HU (1) HUT77379A (hu)
MX (1) MX9700626A (hu)
NO (1) NO310096B1 (hu)
NZ (1) NZ290974A (hu)
WO (1) WO1996003126A1 (hu)
ZA (1) ZA956098B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
PT100566B (pt) * 1991-06-07 1999-06-30 Smithkline Beecham Corp Azaspiranos imunomoduladores, composicoes farmaceuticas que os contem, sua preparacao e seu uso

Also Published As

Publication number Publication date
MX9700626A (es) 1997-05-31
BR9508332A (pt) 1997-11-04
HUT77379A (hu) 1998-04-28
GB9414902D0 (en) 1994-09-14
NO310096B1 (no) 2001-05-21
CZ20997A3 (en) 1997-10-15
JPH10503202A (ja) 1998-03-24
CN1157564A (zh) 1997-08-20
CZ286482B6 (en) 2000-04-12
NO970284L (no) 1997-03-19
KR970704446A (ko) 1997-09-06
NO970284D0 (no) 1997-01-22
EP0804201A1 (en) 1997-11-05
WO1996003126A1 (en) 1996-02-08
HU9700201D0 (en) 1997-04-28
NZ290974A (en) 1999-08-30
AU684384B2 (en) 1997-12-11
AU3190995A (en) 1996-02-22
EP0804201A4 (en) 2000-04-26
CA2195778A1 (en) 1996-02-08

Similar Documents

Publication Publication Date Title
CZ9300230A3 (cs) Kombinační topické prostředky pro léčení bolesti
AU7689791A (en) Drug-free method for treatment of alopecia
HU9202172D0 (en) New n-benzoyl-amino-acid derivatives, medical preparatives containing said compounds and method for producing them
CS149192A3 (en) Pharmaceutical composition, process of its preparation and method offungal infections treating
NO951630L (no) Fremgangsmåte for administrering av azithromycin
PL307669A1 (en) Benzimidazoles, therapeutic agents containing them and method of obtaining such compounds
PL324436A1 (en) Novel derivatives of oxazolydinone, method of obtaining them and therapeutic agents containing such compounds
HU9301869D0 (en) New benzodiazepine derivatives, medical preparatives containing them and method for producing said compounds
PL307169A1 (en) Tetracyclic compounds, method of and intermediate compounds for obtaining them and their application as anticarcinogenic agents
HU914049D0 (en) New leucotriene-b4 derivatives, method for producing them and application of said compounds as medicament
ZA956098B (en) Method of treating opportunistic infections by administration of substituted azaspirane compounds
PL311467A1 (en) Substituted benzoyloguanidines, method of obtaining them and therapeutic agent containing such compounds
GB9419571D0 (en) Treatment of oral infections
GB9202196D0 (en) Method of treatment
AU646074B2 (en) Method of treating poppy
GB9415902D0 (en) Method of treatment
ZA93197B (en) Methods for preventing mycrobacterial infections by administration of rifabutin
GB9407335D0 (en) Method of treatment
GB9201391D0 (en) Method of treatment
ZA946992B (en) Method of treatment of hypertipidema using azaspirane derivatives
RU1769863C (ru) Cпocoб haлoжehия xoлeдoxoдуoдehoahactomoзa
RU1833722C (ru) Cпocoб лeчehия cиhдaktилии
GB9414652D0 (en) Method of treatment
RU1769867C (ru) Cпocoб лeчehия octeomиeлиta
BG95403A (en) Method for the preparation of medicament having antihypertension effect